These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33790054)

  • 41. Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient samples.
    Zhang C; Zhang J; Liang F; Guo H; Gao S; Yang F; Guo H; Wang G; Wang W; Zhou G
    Front Med; 2022 Aug; 16(4):596-609. PubMed ID: 35075579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
    Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
    J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
    Chen L; Xiang Z; Chen X; Zhu X; Peng X
    Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
    Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
    J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
    Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
    Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer.
    Chen H; Chen Q; Chen J; Mao Y; Duan L; Ye D; Cheng W; Chen J; Gao X; Lin R; Lin W; Zhang M; Qi Y
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma.
    Geng X; Chi K; Liu C; Fu Z; Wang X; Meng L; Wang H; Cai G; Chen X; Hong Q
    Front Immunol; 2022; 13():982045. PubMed ID: 36353618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
    Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
    J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promising Therapeutic Targets in Kidney Renal Clear Cell Carcinoma:
    Li CX; Long D; Meng Q
    Cancer Biother Radiopharm; 2024 May; 39(4):276-290. PubMed ID: 34851747
    [No Abstract]   [Full Text] [Related]  

  • 53.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma.
    Cui Y; Zhang C; Wang Y; Ma S; Cao W; Guan F
    Life Sci; 2020 Feb; 243():117230. PubMed ID: 31923422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
    Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
    Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC.
    Li H; Fei M; Zhang Y; Xu Q; Feng R; Cao J; Qu Y; Xiao H
    Gene; 2024 Jul; 914():148403. PubMed ID: 38521112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.
    Qin C; Liu S; Zhou S; Wang Q; Xia X; Hu J; Yuan X; Wang Z; Yu Y; Ma D
    Front Immunol; 2023; 14():1114572. PubMed ID: 37063922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying the role of transient receptor potential channels (TRPs) in kidney renal clear cell carcinoma and their potential therapeutic significances using genomic and transcriptome analyses.
    Ren J; Yuan Q; Liu J; Zhong L; Li H; Wu G; Chen F; Tang Q
    BMC Med Genomics; 2022 Jul; 15(1):156. PubMed ID: 35831825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downregulation of enhancer RNA AC003092.1 is associated with poor prognosis in kidney renal clear cell carcinoma.
    Li J; Gan J; Chen C; Yuan Y; Xiong X; Li L; Luo P; Zhang W
    Sci Rep; 2024 Jun; 14(1):13475. PubMed ID: 38866983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.